Wels WS - Search Results

1

"UniCAR"-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells.

Mitwasi N, Feldmann A, Arndt C, Koristka S, Berndt N, Jureczek J, Loureiro LR, Bergmann R, Máthé D, Hegedüs N, Kovács T, Zhang C, Oberoi P, Jäger E, Seliger B, Rössig C, Temme A, Eitler J, Tonn T, Schmitz M, Hassel JC, Jäger D, Wels WS, Bachmann M. Mitwasi N, et al. Among authors: wels ws. Sci Rep. 2020 Feb 7;10(1):2141. doi: 10.1038/s41598-020-59082-4. Sci Rep. 2020. PMID: 32034289 Free PMC article.

2

Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction.

Uherek C, Tonn T, Uherek B, Becker S, Schnierle B, Klingemann HG, Wels W. Uherek C, et al. Blood. 2002 Aug 15;100(4):1265-73. Blood. 2002. PMID: 12149207 Free article.

3

Regression of cutaneous tumor lesions in patients intratumorally injected with a recombinant single-chain antibody-toxin targeted to ErbB2/HER2.

Azemar M, Djahansouzi S, Jäger E, Solbach C, Schmidt M, Maurer AB, Mross K, Unger C, von Minckwitz G, Dall P, Groner B, Wels WS. Azemar M, et al. Among authors: wels ws. Breast Cancer Res Treat. 2003 Dec;82(3):155-64. doi: 10.1023/b:brea.0000004371.48757.19. Breast Cancer Res Treat. 2003. PMID: 14703062

4

Recombinant immunotoxins and retargeted killer cells: employing engineered antibody fragments for tumor-specific targeting of cytotoxic effectors.

Wels W, Biburger M, Müller T, Dälken B, Giesübel U, Tonn T, Uherek C. Wels W, et al. Cancer Immunol Immunother. 2004 Mar;53(3):217-26. doi: 10.1007/s00262-003-0482-8. Epub 2003 Dec 24. Cancer Immunol Immunother. 2004. PMID: 14704833 Free PMC article. Review.

5

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas.

von Minckwitz G, Harder S, Hövelmann S, Jäger E, Al-Batran SE, Loibl S, Atmaca A, Cimpoiasu C, Neumann A, Abera A, Knuth A, Kaufmann M, Jäger D, Maurer AB, Wels WS. von Minckwitz G, et al. Among authors: wels ws. Breast Cancer Res. 2005;7(5):R617-26. doi: 10.1186/bcr1264. Epub 2005 Jun 1. Breast Cancer Res. 2005. PMID: 16168106 Free PMC article.

6

Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells.

Müller T, Uherek C, Maki G, Chow KU, Schimpf A, Klingemann HG, Tonn T, Wels WS. Müller T, et al. Among authors: wels ws. Cancer Immunol Immunother. 2008 Mar;57(3):411-23. doi: 10.1007/s00262-007-0383-3. Epub 2007 Aug 24. Cancer Immunol Immunother. 2008. PMID: 17717662 Free PMC article.

7

DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma.

Sloots A, Mastini C, Rohrbach F, Weth R, Curcio C, Burkhardt U, Jäger E, Forni G, Cavallo F, Wels WS. Sloots A, et al. Among authors: wels ws. Clin Cancer Res. 2008 Nov 1;14(21):6933-43. doi: 10.1158/1078-0432.CCR-08-1257. Clin Cancer Res. 2008. PMID: 18980988

8

WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation.

Weber G, Karbach J, Kuçi S, Kreyenberg H, Willasch A, Koscielniak E, Tonn T, Klingebiel T, Wels WS, Jäger E, Bader P. Weber G, et al. Among authors: wels ws. Leukemia. 2009 Sep;23(9):1634-42. doi: 10.1038/leu.2009.70. Epub 2009 Apr 9. Leukemia. 2009. PMID: 19357702

9

Maltose-binding protein enhances secretion of recombinant human granzyme B accompanied by in vivo processing of a precursor MBP fusion protein.

Dälken B, Jabulowsky RA, Oberoi P, Benhar I, Wels WS. Dälken B, et al. Among authors: wels ws. PLoS One. 2010 Dec 22;5(12):e14404. doi: 10.1371/journal.pone.0014404. PLoS One. 2010. PMID: 21203542 Free PMC article.

10

NK cells engineered to express a GD2 -specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin.

Esser R, Müller T, Stefes D, Kloess S, Seidel D, Gillies SD, Aperlo-Iffland C, Huston JS, Uherek C, Schönfeld K, Tonn T, Huebener N, Lode HN, Koehl U, Wels WS. Esser R, et al. Among authors: wels ws. J Cell Mol Med. 2012 Mar;16(3):569-81. doi: 10.1111/j.1582-4934.2011.01343.x. J Cell Mol Med. 2012. PMID: 21595822 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page